Carlos H. Barrios

2 ta ish

Hospital São Lucas da PUCRS

1. Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

   Elizabeth A. Mittendorf, Hong Zhang, Carlos H. Barrios +17

   MaqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.098778

2. Enhancing global access to cancer medicines

   Javier Cortés, José Manuel Pérez-García, Antonio Llombart‐Cussac +13

   Sharh maqolaOAOchiq kirishEconomic and Financial Impacts of CancerCA A Cancer Journal for Clinicians20201 iqtibos

   ABIABI:AkademIndex/2026.other.000031